Examples of using Third study in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
The third study compared Alli with placebo in 391 overweight patients with a BMI between 25 and 28 kg/ m2.
In two studies, it was compared with placebo, and the third study also compared it with oxytetracycline another antibiotic.
The third study in mice was carried out with lower dose levels, corresponding to 0, 14, 57, 114 and 857 mg/kg b. w.
Relistor has also been compared with placebo in a third study involving 496 patients with constipation caused by opioids, but no advanced illness.
The third study dedicated itself to the impact of aXbo regarding the morning presentness due to the sleep phase, in which one wakes.
People also translate
In fact, the contrary is the case. A third study on democracy shows that many people actually want more of it.
The third study showed a fall in blood pressure of 8.5 mmHg with Rasilamlo 150/5 mg compared with 8.0 mmHg and 4.8 mmHg with amlodipine 10 mg and 5 mg, respectively.
Bevacizumab, the antibody in the anti-tumour drug Avastin Third study confirming the benefit of Avastin in breast cancer shows that Avastin can be effectively combined with commonly used chemotherapies.
In the third study, Xgeva reduced the risk of developing a first skeletal-related event by 16% compared with zoledronic acid.
High score in social behaviour The third study in the project has an experimental design and will look at directly quantifiable causal relationships between gaming behaviour and its positive effects.
A third study, which involved 900 adults aged 18 to 49, compared the immune response to Prevenar 13 with the response in adults aged 60 to 64.
A third study, using a vaccine with strain A/turkey/Turkey/1/05(H5N1)-like strain(NIBRG-23), has been carried out in 343 adults aged below and above 60 years.
The third study compared the effectiveness of 4 mg/ kg Bridion with that of neostigmine after deep relaxation of the muscles using rocuronium or vecuronium in 182 patients.
The third study included 459 patients who had been taking three antiviral medicines(including lamivudine) for at least 12 weeks and had low levels of HIV in their blood.
A third study examined the use of Privigen for immunomodulation in 28 patients with CIDP who were given Privigen every three weeks over a period of 24 weeks.
The third study uses participant observation to investigate the consumption-related coping process and its relation with other coping mechanisms in relation to the disaster.
The third study found however that there are currently still fewer policies in place for open access to scientific data than for open access to publications.
In the third study dyspnoea was reported more frequently following Rapiscan than placebo, but at a lower rate than reported during clinical development see Section 4.8.
In addition, a third study is ongoing in 5,623 patients where previous treatment with another disease-modifying therapy had failed glatiramer acetate, beta-interferon or fingolimod.
The third study showed that 21 days after the second injection, around 70% of adults below 60 years and around 64% of adults above 60 years produced an acceptable antibody response.
In the third study, patients taking Reyataz or lopinavir, in combination with ritonavir, had similar falls in viral load after 24 and 48 weeks, having fallen by around 99% after 48 weeks.
A third study, D9902A, similar in design to study D9901, was terminated prior to completion of planned accrual based on the time to disease progression results in study D9901.
In a third study on the phenomenon"hacktivism" the Bundeskriminalamt(BKA) was mainly concerned with potential threats posed by"shitstorms" and information campaigns- and thus with generally legitimate expressions….
The third study involved 438 patients whose blood glucose was not adequately controlled by a combination of a GLP-1 agonist(liraglutide or exenatide) and metformin with or without other diabetes medicines taken by mouth.
In the third study dyspnoea was reported more frequently following Rapiscan(18% for patients with COPD; 11% for patients with asthma) than placebo, but at a lower rate than reported during clinical development see Section 4.8.
A third study(study 3) primarily evaluated the safety of Xolair in patients with CSU who remained symptomatic despite treatment with H1 antihistamines at up to four times the approved dose and H2 antihistamine and/or LTRA treatment.
In the third study, IPSS was around 19 points before treatment, falling by 7.0 points in the men who took Silodyx after 12 weeks, 6.7 points in the men who took tamsulosin and 4.7 points in the men who took placebo.
A third study investigated the effects of Ulunar Breezhaler on the rate of exacerbations(flare-ups) patients experienced during 64 weeks of treatment when compared with treatment with glycopyrronium or tiotropium other treatments for COPD.
A third study, in 578 patients whose disease had not responded or had come back after previous treatment, compared adding Imbruvica or placebo(a dummy treatment) to the cancer medicines bendamustine and rituximab.
The third study showed that Halaven was effective at prolonging life in patients with liposarcoma: patients treated with Halaven lived for an average of 15.6 months, compared with 8.4 months for patients treated with dacarbazine.